Your browser doesn't support javascript.
loading
Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection.
Desai, Angel N; Thompson, George R; Neumeister, Sonja M; Arutyunova, Anna M; Trigg, Katelyn; Cohen, Stuart H.
Affiliation
  • Desai AN; Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California.
  • Thompson GR; Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California.
  • Neumeister SM; Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California.
  • Arutyunova AM; Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California.
  • Trigg K; Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California.
  • Cohen SH; Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California.
JAMA ; 328(13): 1348-1350, 2022 10 04.
Article in En | MEDLINE | ID: mdl-35994281
This case series describes the clinical resolution of systemic symptoms and lesions, along with any adverse events, in patients with monkeypox infection who were treated with tecovirimat on a compassionate use basis.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Phthalimides / Benzamides / Mpox (monkeypox) / Compassionate Use Trials Limits: Humans Language: En Journal: JAMA Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Phthalimides / Benzamides / Mpox (monkeypox) / Compassionate Use Trials Limits: Humans Language: En Journal: JAMA Year: 2022 Document type: Article